Top Page
Idox plc
(LSE:IDOX)
Idox plc (IDOX) vs. iShares MSCI United Kingdom ETF (EWC)
Idox plc Business Overview & Revenue Model
Idox plc Financial Statement Overview
| Breakdown | |||||
| TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 80.64M | 87.60M | 73.28M | 66.18M | 62.19M | 68.02M | Gross Profit |
| 61.52M | 63.08M | 57.24M | 51.13M | 45.05M | 49.21M | EBIT |
| 10.59M | 10.01M | 9.34M | 8.66M | 7.64M | 4.92M | EBITDA |
| 22.51M | 22.04M | 20.31M | 18.90M | 18.54M | 14.11M | Net Income Common Stockholders |
| 5.50M | 5.26M | 5.58M | 5.04M | 6.03M | 1.28M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 7.02M | 11.66M | 14.82M | 13.86M | 18.28M | 30.81M | Total Assets |
| 115.88M | 146.48M | 151.47M | 130.03M | 133.57M | 138.32M | Total Debt |
| 33.39M | 23.51M | 30.68M | 22.34M | 28.87M | 50.78M | Net Debt |
| 26.37M | 11.85M | 15.85M | 8.47M | 10.58M | 19.97M | Total Liabilities |
| 71.26M | 68.20M | 78.20M | 62.61M | 72.76M | 91.36M | Stockholders Equity |
| 44.72M | 78.28M | 73.28M | 67.42M | 60.81M | 46.96M |
| Cash Flow | Free Cash Flow | ||||
| 8.37M | 12.44M | 10.08M | 8.09M | 10.81M | 14.42M | Operating Cash Flow |
| 17.40M | 21.11M | 18.60M | 15.65M | 16.55M | 21.35M | Investing Cash Flow |
| -22.34M | -11.00M | -22.55M | -9.84M | -5.54M | -7.12M | Financing Cash Flow |
| -1.07M | -13.63M | 4.71M | -10.62M | -23.08M | 9.46M |
Idox plc Technical Analysis
Idox plc Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £235.05M | 20.76 | 11.66% | 1.44% | 11.38% | -8.44% | |
77 Outperform | £138.12M | 40.86 | 11.59% | 0.51% | 15.67% | 25.62% | |
73 Outperform | £286.36M | 45.84 | 8.06% | 1.11% | 10.93% | 12.30% | |
73 Outperform | £200.25M | 29.30 | 4.56% | ― | -0.90% | 15.22% | |
72 Outperform | £197.62M | 37.98 | 12.87% | 0.75% | 15.40% | -6.59% | |
71 Outperform | £92.90M | 16.89 | 10.98% | 1.50% | 4.97% | 3.63% | |
62 Neutral | $11.91B | 9.99 | -7.22% | 4.96% | 7.31% | -8.91% |
Idox plc Corporate Events
Idox plc reported a strong financial performance for the first half of 2025, with a 4% increase in revenue and a 6% rise in Adjusted EBITDA compared to the previous year. The company achieved a record order intake and continued to expand its market presence through strategic acquisitions, including the purchase of Plianz, a health and social care software provider. Idox’s growth strategy is supported by a robust M&A pipeline and a focus on recurring revenue, which rose by 9%. The company remains well-positioned to meet its full-year expectations, with strong demand for its cloud-based solutions and a commitment to delivering value to customers and shareholders.
Idox plc, a company listed on the UK stock exchange, has announced a change in its major holdings. Canaccord Genuity Group Inc., based in Vancouver, Canada, has increased its voting rights in Idox plc to 11.0438%, up from a previous position of 10.9757%. This change reflects an acquisition or disposal of voting rights, impacting the overall voting power within the company.
The most recent analyst rating on (GB:IDOX) stock is a Buy with a £0.80 price target. To see the full list of analyst forecasts on Idox plc stock, see the GB:IDOX Stock Forecast page.
Idox plc, a UK-based company, has announced a change in its major holdings as Canaccord Genuity Group Inc, based in Vancouver, Canada, has adjusted its voting rights in the company. The notification indicates that Canaccord Genuity Group Inc’s voting rights in Idox plc have slightly decreased to 10.9757% from a previous position of 11.0004%. This change reflects a minor adjustment in the financial instruments held by Canaccord Genuity and may have implications for the company’s shareholder structure.
The most recent analyst rating on (GB:IDOX) stock is a Buy with a £0.80 price target. To see the full list of analyst forecasts on Idox plc stock, see the GB:IDOX Stock Forecast page.
Idox plc, a company involved in providing software and services, has received a notification regarding a change in major holdings. Canaccord Genuity Group Inc., based in Vancouver, Canada, has adjusted its voting rights in Idox plc, now holding 10.9885% of the voting rights, a slight decrease from a previous position of 11.0058%. This change in holdings could impact the company’s governance and decision-making processes, potentially influencing strategic directions and stakeholder interests.
The most recent analyst rating on (GB:IDOX) stock is a Buy with a £0.80 price target. To see the full list of analyst forecasts on Idox plc stock, see the GB:IDOX Stock Forecast page.
Idox plc, a company involved in software and information services, has announced a change in its major holdings. Canaccord Genuity Group Inc., based in Vancouver, Canada, has increased its voting rights in Idox plc to 11.0004% from a previous position of 10.9885%. This acquisition of voting rights indicates a strategic move by Canaccord Genuity Group Inc. to strengthen its influence within Idox plc, which may have implications for the company’s governance and future strategic decisions.
The most recent analyst rating on (GB:IDOX) stock is a Buy with a £0.80 price target. To see the full list of analyst forecasts on Idox plc stock, see the GB:IDOX Stock Forecast page.
Idox plc, a company involved in providing software solutions and services, has announced a change in the voting rights held by Canaccord Genuity Group Inc. The notification indicates that Canaccord Genuity Group Inc., based in Vancouver, Canada, has adjusted its voting rights in Idox plc to 10.9897%, down from a previous position of 11.0188%. This change reflects an acquisition or disposal of voting rights, impacting the company’s shareholder structure and potentially influencing its governance dynamics.
The most recent analyst rating on (GB:IDOX) stock is a Buy with a £0.80 price target. To see the full list of analyst forecasts on Idox plc stock, see the GB:IDOX Stock Forecast page.
Idox plc reported a strong performance for the first half of 2025, with a revenue increase to approximately £45.0 million and a significant rise in order intake. The company achieved a net cash position, reducing from a previous net debt, and completed the acquisition of Plianz to enhance its Social Care offerings. This positive momentum positions Idox well for continued growth in 2025.
The most recent analyst rating on (GB:IDOX) stock is a Buy with a £0.80 price target. To see the full list of analyst forecasts on Idox plc stock, see the GB:IDOX Stock Forecast page.
Idox plc has announced the acquisition of Trojan Consultants Limited, trading as Plianz, a UK-based provider of Social Care software solutions. This acquisition, valued at up to £7.9 million, is expected to enhance Idox’s Social Care business by integrating Plianz’s automated software solutions, which focus on financial management for vulnerable individuals. The move is part of Idox’s strategy to expand its public sector software offerings, leveraging Plianz’s capabilities to grow its customer base and solution reach within the Social Care sector.
The most recent analyst rating on (GB:IDOX) stock is a Buy with a £0.80 price target. To see the full list of analyst forecasts on Idox plc stock, see the GB:IDOX Stock Forecast page.
Idox plc has reported a positive start to the current financial year, with trading aligning with the Board’s expectations for increased revenue and adjusted EBITDA, alongside a reduction in net debt for FY25. The company has secured new contracts and extensions across all business areas, bolstering confidence in future growth. The firm’s strong financial resources position it well for potential acquisitions, while its focus on high-quality recurring revenue and repeatable services supports its growth strategy amidst economic uncertainties.